Navigation Links
Nine Questions to Help You Protect Your Heart Before Having Surgery
Date:11/27/2007

BOSTON, Nov. 27 /PRNewswire-USNewswire/ -- It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery. What's needed to protect the heart during such operations? The December issue of the Harvard Heart Letter offers nine questions to help you and your doctor determine if you need cardiac testing or treatment before undergoing surgery.

New guidelines from the American College of Cardiology and American Heart Association take some of the stress--and stress testing--out of surgery. They limit the use of pre-surgery stress testing, especially before low-risk procedures such as colonoscopy, cataract removal, and most outpatient surgeries. For higher-risk operations, like surgery on the aorta or other blood vessels, prostate surgery, or bone or joint surgery, whether you need testing and preventive care depends on the state of your heart. People with an active heart condition such as unstable heart failure, a significant heart rhythm problem, or severe valve disease need pre-surgery cardiac evaluation, and possibly treatment, more than those with stable, well-controlled heart disease.

The Harvard Heart Letter's questions include these:

-- How urgent is the operation? In an emergency, there's no time to second-guess cardiac risk. If the surgery can be delayed, cardiac considerations become more important.

-- What's your functional status? Can you climb stairs without needing to stop because of chest pain or breathlessness? The more you're able to do, the less you need a presurgical cardiac evaluation.

-- Do you have cardiac risk factors? Angina, diabetes, kidney disease, controlled heart failure, or a prior stroke increase the chances of heart trouble during surgery. If you don't have any of these risk factors, you probably don't need special precautions before surgery.

Also in this issue:

-- Geneti
'/>"/>

SOURCE Harvard Heart Letter
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise
2. Study Questions Dead-End Cancer Clinical Trials
3. 6 Years Later, 9/11 Health Questions Linger
4. RFID Implant Cancer Questions Concern Patients
5. Study Questions Genetic Screening for Treatable Diseases
6. New study questions the validity of publishing hospital mortality rates
7. Study Questions Flu Shots Value for Older People
8. Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology
9. Study questions assumptions about human sensitivity to biological motion
10. Childrens Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection
11. New study questions disparities in vascular surgery among Hispanics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...local dance students will dance to raise money for...S, Jan. 8 , , , WHO: ...how off their talent in the 3rd annual Dance, ...nce Arts Centre. The, event will ..., Participants raise money throug...
(Date:1/8/2009)..., Md., Jan. 8 /PRNewswire-Asia/ -- Chindex Interna...mpany"), a leading independent American,provider ... People,s Republic,of China, today announced that...na Conference, to be held in Shanghai on January 1...Conference will be held at the Pudong Shangri-,La...
(Date:1/8/2009)...romoted to Principal. Christine Siu and Jason Bro...POLIS, SAN FRANCISCO and STAMFORD, Conn., Jan. 8 /...health care venture capital firm that invests in l...y announced the promotion of three members of its ...Principal. Christine Siu and Jason Brown have bee...
(Date:1/8/2009)... Tenn., Jan. 8 St. Jude Children,s...p announced that FedExCup Runner-Up,Camilo Villeg...Jude with a,pledge to match Singh,s donation of $... 2009 PGA TOUR. Eagles for St. Jude is a powerful...ion Vijay Singh and rising LPGA star Morgan,Press...
Breaking Medicine News(10 mins):Health News:Dance With Courage to Benefit Camp Courage 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...gers drawn on many issues, however one issue that ...ent in India of 70 poor Pakistani children later t...s likely to pave path towards many more similar ge... the two countries that politician on both sides o...
... stents that release the medication paclitaxel red...nths following angioplasty for patients with compl...e in the September 14 issue of JAMA. Drug-eluting ... of atherosclerotic coronary artery disease, accor...
...n Uttar Pradesh crossed 800 Saturday. But the admi... believed to be at the root of the virtual epidemi...orse as the animal is known to be the biggest host...carried across to human beings by mosquitoes. Utt...
... the heart from the use of stem cells. French rese...o repair heart damage in sheep, reporting their re...ncet. Heart failure is a major cause of death in d... when cells within the heart are damaged after a h...
Other Medicine News:Health News:Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childr 2Health News:Stents That Release Medication To Check Artery Narrowing 2Health News:Pigs Population A Major Threat To Encephalitis Ravaged UP 2
(Date:1/5/2009)...e/ -- Cylene Pharmaceuticals announced today that ...ral CK2 protein kinase inhibitor, CX-4945, in pati...se, or multiple myeloma. The primary endpoints of ...f safety, tolerance and PK properties of CX-4945 a...als. In addition, multiple mechanism-related pharm...
(Date:12/30/2008)...ire-USNewswire/ -- The Coalition for 21st Century ...ed by Genentech, Inc. on December 5, 2008, seeking...diagnostic tests to physicians and patients. The ...would harm patient care and rests on flawed scient...ssion is to encourage the research, development, a...
(Date:12/27/2008)...-year silence, offers to ease cloning costs for Cl...S, Dec. 27 Six years to...oned child, Dr. Brigitte Boisselier, head of the c...d other babies cloned by her company are growing u...eir families, privacy. , , "We,ve helped almost...
(Date:12/17/2008)...wswire/ -- PEAK Surgical, Inc., a medical,device ... system based on a,proprietary technology, announ...ion (FDA) has granted the company 510(k) clearance... and coagulation of soft tissue during,plastic an...cologic,orthopedic, arthroscopic, spinal and neu...
Breaking Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4'We're Ready to Prove It!' 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Breckenridge Pharmaceutical Enters Agreement With Helm AG 28Hamburg Germany 29 to Develop Additional ANDA Project 15702 1CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 1CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 2CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 3mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 1mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 2mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 3mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 4mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 5Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 1Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 2Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 3Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 4Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 5Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 6
...SS WIRE)--Mar 26, 2007 - A study comparing,the for...lazine,(HYD) used in V-HeFT I and V-HeFT II, and B... in the African American Heart Failure,Trial (A-He...ence,in the formulations used may explain why V-He...n decreasing mortality. Using,identical amounts of...
...already being treated with maximally,tolerated lip...ctions in LDL-C with similar reductions in other a...12, NEW ORLEANS, and CARLSBAD, Calif., March 26, 2..., Inc. announced,results from its ongoing Phase 2 ...ozygous familial hypercholesterolemia (HoFH),pres...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: